Adhesion and migration of extracellular matrix-stimulated breast cancer

Journal of Surgical Research

Volumn 110, Issue 1, 2003, Pages 287-294

  Bartsch, John E ^a   Staren, Edgar D ^a   Appert, Hubert E ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Adhesion; Breast cancer; Extracellular matrix; Fibronectin; Migration; Vitronectin

Indexed keywords

10,11 DIHYDRO 3 [3 (2 PYRIDINYLAMINO)PROPOXY] 5H DIBENZO[A,D]CYCLOHEPTENE 10 ACETIC ACID; CHEMICAL COMPOUND; FIBRONECTIN; INTEGRIN; PEPTIDOMIMETIC AGENT; SB 223245; UNCLASSIFIED DRUG; VITRONECTIN;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CELL MIGRATION; DRUG EFFECT; EXTRACELLULAR MATRIX; PRIORITY JOURNAL;

EID: 0037357315     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00004-0     Document Type: Article

References (30)

1. Mizejewski G.J. Role of integrins in cancer Survey of expression patterns . Proc. Soc. Exp. Biol. Med. 222:1999;124.
2. Crowe D.L., Shuler C.F. Regulation of tumor cell invasion by extracellular matrix. Histol. Histopathol. 14:1999;665.
3. Shaw L.M. Integrin function in breast carcinoma progression. J. Mammary Gland Biol. Neoplasia. 4:1999;367.
4. Zutter M.M., Mazoujian G., Santoro S.A. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am. J. Pathol. 137:1990;863.
5. Friedrichs K., Ruiz P., Franke F., Gille I., Terpe H.J., Imhof B.A. High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res. 55:1995;901.
6. Mukhopadhyay R., Theriault R.L., Price J.E. Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells. Clin. Exp. Metastasis. 17:1999;325.
7. Dedhar S. Integrin mediated signal transduction in oncogenesis An overview . Cancer Metastasis Rev. 14:1995;165.
8. Lafrenie R.M., Yamada K.M. Integrins and matrix molecules in salivary gland cell adhesion, signaling, and gene expression. Ann. NY Acad. Sci. 842:1998;42.
9. Miyamoto S., Katz B.Z., Lafrenie R.M., Yamada K.M. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Ann. NY Acad. Sci. 857:1998;119.
10. Johansson S., Svineng G., Wennerberg K., Armulik A., Lohikangas L. Fibronectin-integrin reactions. Front. Biosci. 2:1997;d126.
11. Humphries M.J., Olden K., Yamada K.M. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science. 233:1986;467.
12. Ohnishi T., Arita N., Hiraga S., Taki T., Izumoto S., Fukushima Y., Hayakawa T. Fibronectin-mediated cell migration promotes glioma cell invasion through chemokinetic activity. Clin. Exp. Metastasis. 15:1997;538.
13. Felding-Habermann B., Cheresh D.A. Vitronectin and its receptors. Curr. Opin. Cell Biol. 5:1993;864.
14. Filardo E.J., Deming L., Cheresh D.A. Regulation of cell migration by the integrin beta subunit ectodomain. J. Cell Sci. 109:1996;1615.
15. Melchiori A., Mortarini R., Carlone S., Marchisio P.C., Anichini A., Noonan D.M., Albini A. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. Exp. Cell Res. 219:1995;233.
16. Liu Z., Brattain M.G., Appert H.E. Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435 versus the poorly invasive cell line, MCF-7. Biochem. Biophys. Res. Comm. 231:1997;283.
17. Price J.E., Polyzos A., Zhang R.D., Daniels L.M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50:1990;717.
18. Meyer T., Marshall J.F., Hart I.R. Expression of αv integrins and vitronectin receptor identity in breast cancer cells. Br. J. Cancer. 77:1998;530.
19. Wong N.C., Mueller B.M., Barbas C.F., Ruminski P., Quaranta V., Lin E.C.K., Smith J.W. αv Integrins mediate adhesion and migration of breast carcinoma cell lines. Clin. Exp. Metastasis. 16:1998;50.
20. Clezardin P. Recent insights into the role of integrins in cancer metastasis. Cell. Mol. Life Sci. 54:1998;541.
21. Batt D.G., Petraitis J.J., Houghton G.C., Modi D.P., Cain G.A., Corjay M.H., Mousa S.A., Bouchard P.J., Forsythe M.S., Harlow P.P., Barbera F.A., Spitz S.M., Wexler R.R., Jadhav P.K. Disubstituted indazoles as potent antagonists of the integrin αvβ3. J. Med. Chem. 43:2000;41.
22. Dechantsreiter M.A., Planker E., Mathä B., Lohof E., Hölzemann G., Jonczyk A., Goodman S.L., Kessler H. N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists. J. Med. Chem. 42:1999;3033.
23. Lark M.W., Stroup G.B., Hwang S.M., James I.E., Rieman D.J., Drake F.H., Bradbeer J.N., Mathur A., Erhard K.F., Newlander K.A., Ross S.T., Salyers K.L., Smith B.R., Miller W.H., Huffman W.F., Gowen M. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis. J. Pharmacol. Exp. Ther. 291:1999;612.
24. Ward K.W., Azzarano L.M., Bondinell W.E., Cousins R.D., Huffman W.F., Jakas D.R., Keenan R.M., Ku T.W., Lundberg D., Miller W.H., Mumaw J.A., Newlander K.A., Pirhalla J.L., Roethke T.J., Salyers K.L., Souder P.R., Stelman G.J., Smith B.R. Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonist. Drug Metab. Dispos. 27:1999;1231.
25. Gui G.P.H., Puddefoot J.R., Vinson G.P., Wells C.A., Carpenter R. In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix. Br. J. Surg. 82:1995;1192.
26. Lin E.C.K., Carron C.P., Meyer D.M., Smith J.W. A series of function blocking antibodies against the αvβ3 integrin bind allosteric to the ligand binding site and induce ligand dissociation. Cell. Adhes. Commun. 6:1998;451.
27. Fukushima Y., Ohnishi T., Arita N., Hayakawa T., Sekiguchi K. Integrin α3β1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells. Int. J. Cancer. 76:1998;63.
28. Mould A.P., Askari J.A., Aota S., Yamada K.M., Irie A., Takada Y., Mardon M.J., Humphries M.J. Defining the topology of integrin α5β1-fibronectin interactions using inhibitory anti-α5 and anti-β1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the α5 subunit. J. Biol. Chem. 272:1997;17283.
29. Burrows L., Clark K., Mould A.P., Humphries M.J. Fine mapping of inhibitory anti-α5 monoclonal antibody epitopes that differentially affect integrin-ligand binding. Biochem. J. 344:1999;527.
30. Doerr M.E., Jones J.I. The role of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J. Biol. Chem. 271:1996;2443.